Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber - Roux, Michel; Devillier, Philippe; Yang, William H.; Montagut, Armelle; Abiteboul, Kathy; Viatte, Agnès; Zeldin, Robert K. (Journal of allergy and clinical immunology, 2016)
Keywords: Adult; Allergen immunotherapy; allergic rhinitis; Allergies; Allergy and Immunology; Antigens, Dermatophagoides - administration & dosage; Antigens, Dermatophagoides - immunology; Area Under Curve; Asthma; Dermatophagoides pteronyssinus; dose-ranging; double-blind placebo-controlled trial; Environmental Exposure; environmental exposure chamber; Female; Forced Expiratory Volume; house dust mite; Humans; Immunoglobulin E - immunology; Immunoglobulin G - immunology; Immunotherapy; Investigations; Male; Nose; Rhinitis, Allergic - diagnosis; Rhinitis, Allergic - immunology; Rhinitis, Allergic - therapy; Sublingual Immunotherapy - adverse effects; Sublingual Immunotherapy - methods; sublingual immunotherapy tablet; Treatment Outcome; Young Adult; dose-ranging; EEC; house dust mite; AE; RTSS; double-blind placebo-controlled trial; IR; VAS; environmental exposure chamber; AIT; ARSS; AUC; ChBL; AVASS; HDM; sublingual immunotherapy tablet; TEAE; ARTSS; allergic rhinitis; Allergen immunotherapy; Average Rhinitis Symptom Score; Visual Analog Scale; Index of reactivity; Rhinitis Total Symptom Score; Area under the curve; Ch BL; Average Rhinitis Total Symptom Score; Average Visual Analog Scale Score; Change from baseline; Adverse event; Treatment-emergent adverse event